ClinicalTrials.gg
CompletedNCT04162626NFUpdated Jan 13, 2025

New Families- Innovation and Development of the Child Health Services in Oslo

An interventional study of Supportive home visits to new families and Treatment as usual in Primary Prevention, sponsored by VID Specialized University. Completed at 1 site in Norway. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-13.

Sponsored by VID Specialized University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Oct 2018, registered Nov 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
428
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The New Families (NF) program will improve quality of existing services, secure personalised service and early intervention in Child Health Service (CHS) in Oslo. The study will measure the effects of a primary prevention family-centered healthcare intervention in Norwegian CHS.

Read the detailed description

The New Families (NF) program will improve quality of existing services, secure personalised service and early intervention in Child Health Service (CHS) in Oslo. The study will: 1) Measure the effects of a primary prevention family-centered healthcare intervention in Norwegian CHS, 2) Create case studies from CHS praxis advancing Public Health Nurse (PHN) training and education in Oslo and Norway, 3) Establish a model for how to include users in service development in CHS, 4) Enhance the knowledge base of the PHN practice in CHS Anticipated results: The project will bolster the knowledge base for education and professional practices within the service by strengthen the existing research within the field. The anticipated results of the project are that the intervention will increase maternal and parental self-efficacy, reduce the risk of postpartum depression among first-time mothers, reduce parental stress, increase social support, improve maternal attachment, improve generic health status, improve partner relationship and improve child development compared with usual care. The intervention research in this project can be a future model for service improvement in the CHS.

02

Conditions studied

  • Primary Prevention

Keywords

  • public health nurse
  • intervention
  • home visit
03

In context

Lead sponsor

VID Specialized University is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First time parents living in the chosen districts

Exclusion criteria

Exclusion Criteria:

  • All other parents
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
428 participants (actual)

Study arms

  • Experimental
    Intervention

    Supportive home visits by public health nurses to new parents from 28 weeks in pregnancy until the child is two years.

    Other: Supportive home visits to new families

  • Other
    Control

    Follow up as usual at the Child health center

    Other: Treatment as usual

Interventions

  • OtherSupportive home visits to new families

    The new families are offered home visits by a public health nurse from 28 weeks in pregnancy until the child is two years old. The number of home visits depends on the families needs and wishes. They also get the usual follow up from the Child health center.

  • OtherTreatment as usual

    Follow up at the Child health center according to national regulations

06

What researchers measure

Primary outcomes

  1. Depression in mothers in pregnancy

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Time frame: 28 weeks pregnancy

  2. Depression in fathers when partner is pregnant

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Time frame: 28 weeks pregnancy

  3. Depression in mothers three months postpartum

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Time frame: 3 months postpartum

  4. Depression in fathers three months postpartum

    Edinburgh postnatal depression scale (EPDS). 10 items. Score 0-30. Score 12 or above indicate postpartum depression.

    Time frame: 3 months postpartum

  5. Sense of Coherence in mothers in pregnancy

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Time frame: 28 weeks pregnancy

  6. Sense of Coherence in fathers in pregnancy

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Time frame: 28 weeks pregnancy

  7. Sense of Coherence in mothers three months postpartum

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Time frame: 3 months postpartum

  8. Sense of Coherence in fathers three months postpartum

    Sense of Coherence Scale (SOC 13). 26 items. Score 13-90. Higher score is positive, score under 66 is low.

    Time frame: 3 months postpartum

  9. Self-Efficacy in mothers 6 weeks postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Time frame: 6 weeks postpartum

  10. Self-Efficacy in fathers 6 weeks postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Time frame: 6 weeks postpartum

  11. Self-Efficacy in mothers 3 months postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Time frame: 3 months postpartum

  12. Self-Efficacy in fathers 3 months postpartum

    Perceived Maternal Parenting Self-Efficacy (PMP S-E) 20 items. score 22-88. A higher score indicates a higher level of maternal self-efficacy

    Time frame: 3 months postpartum

  13. Parental Stress in fathers 3 months postpartum

    Parental Stress Scale (PSS) is formatted in the form of an 18-item self-report scale. Items represent positive (e.g. emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood. A higher score indicates a higher level of parental stress.

    Time frame: 3 months postpartum

  14. Parental Stress in mothers 3 months postpartum

    Parental Stress Scale (PSS) is formatted in the form of an 18-item self-report scale. Items represent positive (e.g. emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood. A higher score indicates a higher level of parental stress.

    Time frame: 3 months postpartum

  15. Quality of Life in women and men during pregnancy and postpartum

    To explore first-time parents' QoL during pregnancy and first-time mothers QoL postpartum, and to evaluate the difference in QoL between mothers in the intervention and control districts. Instrument: WHOQOL-BREF, 26-item. Score 4-20, higher scores indicate higher QoL.

    Time frame: Pregnancy week 28, 3 months postpartum, 12 months postpartum.

Secondary outcomes

  1. What are the barriers and facilitators to implementation of the PHN intervention?

    This research question will be explored by addressing the process of implementation. Data will be collected through a short survey and semi-structured interviews with PHNs and users (first-time mothers/fathers). An interview guide will be developed

    Time frame: The interviews will take place about 12 months postpartum

07

Study locations

1 site
  • VID Specialized University
    Oslo, NO-0319, Norway
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — There will be four doctoral students (PhD) in the project

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2018 to primary completion in Jun 2021, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2019
First posted
Nov 14, 2019
StartActual
Oct 8, 2018
Primary completionActual
Jun 1, 2021
CompletionActual
Oct 1, 2021
Last update
Jan 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04162626
Lead sponsor
VID Specialized University
Collaborators
Municipality of Oslo, Norway, University of Oslo, Norwegian Institute of Public Health, The Research Council of Norway
Responsible party
Kari Glavin (Professor, VID Specialized University) — Principal investigator
First posted
Nov 14, 2019
Start date
Oct 8, 2018
Primary completion
Jun 1, 2021
Completion
Oct 1, 2021
Last update
Jan 13, 2025

Study contacts

Kari Glavin, PhD
principal investigator · VID Specialized University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion